Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis.

Pewarchuk WJ, Fernandez-Rachubinski F, Rachubinski RA, Blajchman MA.

Thromb Res. 1990 Aug 15;59(4):793-7. No abstract available. Erratum in: Thromb Res 1991 Jan 1;61(1):91.

PMID:
2093312
2.

Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.

Okajima K, Abe H, Wagatsuma M, Okabe H, Takatsuki K.

Am J Hematol. 1995 Jan;48(1):12-8.

PMID:
7832187
3.

Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.

Caso R, Lane DA, Thompson EA, Olds RJ, Thein SL, Panico M, Blench I, Morris HR, Freyssinet JM, Aiach M, et al.

Br J Haematol. 1991 Jan;77(1):87-92.

PMID:
1998601
4.

Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.

Olds RJ, Lane D, Caso R, Tripodi A, Mannucci PM, Thein SL.

Nucleic Acids Res. 1989 Dec 25;17(24):10511. No abstract available.

5.

A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.

Aiach M, Nora M, Fiessinger JN, Roncato M, François D, Gelas MA.

Thromb Res. 1985 Sep 1;39(5):559-70.

PMID:
4082101
6.

Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity.

Devraj-Kizuk R, Chui DH, Prochownik EV, Carter CJ, Ofosu FA, Blajchman MA.

Blood. 1988 Nov;72(5):1518-23.

7.

Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.

Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M, Nagataki S, Okabe H, Takatsuki K.

Blood. 1993 Mar 1;81(5):1300-5.

8.

A Swedish family with abnormal antithrombin III.

Tengborn L, Frohm B, Nilsson LE, Nilsson IM.

Scand J Haematol. 1985 May;34(5):412-6.

PMID:
4012220
9.

Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.

Tripodi A, Krachmalnicoff A, Mannucci PM.

Thromb Haemost. 1986 Dec 15;56(3):349-52.

PMID:
3563966
10.

A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis.

Saleun S, De Moerloose P, Bura A, Aiach M, Emmerich J.

Blood Coagul Fibrinolysis. 1996 Jul;7(5):578-9.

PMID:
8874869
11.

Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis.

Millar DS, Lopez A, White D, Abraham G, Laursen B, Holding S, Reverter JC, Reynaud J, Martinowitz U, Hayes JP, et al.

Hum Mutat. 1993;2(4):324-6. No abstract available.

PMID:
8401542
12.

Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.

Molho-Sabatier P, Aiach M, Gaillard I, Fiessinger JN, Fischer AM, Chadeuf G, Clauser E.

J Clin Invest. 1989 Oct;84(4):1236-42.

13.

Antithrombin III-Amiens: a new family with an Arg47----Cys inherited variant of antithrombin III with impaired heparin cofactor activity.

Roussel B, Dieval J, Delobel J, Fernandez-Rachubinski F, Eng B, Rachubinski RA, Blajchman MA.

Am J Hematol. 1991 Jan;36(1):25-9.

PMID:
1984678
14.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
15.

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.

J Clin Invest. 1986 Mar;77(3):887-93.

16.

Familial functional antithrombin III deficiency.

Sørensen PJ, Dyerberg J, Stoffersen E, Jensen MK.

Scand J Haematol. 1980 Feb;24(2):105-9.

PMID:
7375809
17.

Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.

Lane DA, Lowe GD, Flynn A, Thompson E, Ireland H, Erdjument H.

Br J Haematol. 1987 Aug;66(4):523-7.

PMID:
3663509
18.

A novel missense mutation in the antithrombin III gene (Ser349----Pro) causing recurrent venous thrombosis.

Grundy CB, Holding S, Millar DS, Kakkar VV, Cooper DN.

Hum Genet. 1992 Mar;88(6):707-8. No abstract available.

PMID:
1551681
19.

[Hereditary abnormalities of antithrombin III in patients with recurrent thrombophlebitis].

Bekić-Kaluza S, Rezaković D, Musa M.

Med Arh. 1986;40(1-2):51-3. Croatian. No abstract available.

PMID:
3272307
20.

Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N.

Proc Natl Acad Sci U S A. 1984 Jan;81(2):289-93.

Supplemental Content

Support Center